Global pharmaceutical giant Eli Lilly ... plant in northeast Houston, a potential economic jolt that could accelerate the city’s ambitions to become a national hub for biomanufacturing. The ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY ...

The Indiana-based company first announced in February that it was scouting several states for a $27 billion investment into several new facilities. Eli Lilly opened a portal at the time for states ...

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out potential sites for new drug ingredients plants. Eli Lilly is jockeying for a ...

Lilly in February announced plans to add four U.S. manufacturing sites at yet-to-be-determined sites as part of a roughly $27 billion investment.

Pharma giant Eli Lilly is planning a $5.9 billion investment for a massive pharmaceutical manufacturing facility in McCord Development’s Generation Park, a potential anchor for the city’s ...

Eli Lilly is considering a 236-acre tract of McCord Development’s Generation Park for the manufacturing plant, which would ... double its U.S. manufacturing investment, bringing its capital ...

Eli Lilly seems to have responded to the ... shortages, and reduced investment in R&D. Lilly's announcement comes just a few days after Lilly's chief executive, David Ricks, and other pharma ...

TeamSense ranked all 50 states and the District of Columbia by their level of search interest in manufacturing topics.